Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Sarepta Shares Get a 35% Boost from FDA Approval of 2nd DMD Drug

Sarepta Therapeutics shares traded 35% higher after the firm reported that the FDA approved its second RNA exon-skipping treatment drug VYONDYS 53 injection for the treatment of Duchenne's Muscular Dystrophy in patients amenable to skipping Exon 53. Yesterday evening,...
Streetwise Reports | December 16, 2019 |

Natural gas: Future of the auto industry?

As billionaire T. Boone Pickens and politicians on Capitol Hill debate whether to offer tax credits to help facilitate a transition to natural-gas-fueled trucking fleets, U.S. automakers Chrysler and General Motors ( NYSE: GM , Stock Forum ) are rolling out their own pl...
Robert Ross | October 28, 2012 |

Where is the Top for Natural Gas?

We wrote a very telling research article on October 24 th , 2019. We never published it because we had other articles scheduled to be published over the next few weeks in the queue and because our subscribers get our trade alerts before the general public. At this point, we ar...
Chris Vermeulen | November 8, 2019 |

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. Biopharmaceutical firm Retrophin Inc. (RTRX:NASDAQ) shares are trading much lower today as the co...
Streetwise Reports | August 26, 2019 |

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...
Streetwise Reports | September 6, 2019 |

This Is What First Lagarde’s Speech Means for Gold

In November, Lagarde delivered her first speech as the ECB President. Will she follow in Draghi’s footsteps? But what should gold investors expect from her? Key Takeaways from Lagarde’s Speech Recently, we have focused on the U.S. econo...
Arkadiusz Sieron | December 6, 2019 |

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-20...
Streetwise Reports | December 12, 2019 |

Buzz on the Bullboards: Do the Dead Cats Bounce?

(Image via CGX Energy Inc.) You’ve heard that what goes up must come down, but in the stock trading world, what goes down should come up. Even a dead cat can bounce if it falls from high enough up, right? The markets coined this term believing th...
Stockhouse Editorial | May 11, 2022 |

Has the Basing Setup In Natural Gas Completed?

Back in June 2019, we posted a research article suggesting that Natural Gas was setting up an extended basing pattern below $2.35 preparing for a seasonal rally that typically initiates in late August or early September. We believe the basing pattern has nearly completed and n...
Chris Vermeulen | August 27, 2019 |

Natural Gas and Crude Oil – Diverging Setups For Technical Traders

Over the past few weeks and months, we've been alerting our followers to the incredible setups in Natural Gas and Crude Oil. If you've been following our research, you already know on May 21st we called for Oil to break down from $62 level with a target of $55 then $49 pri...
Chris Vermeulen | August 13, 2019 |
1 2 3 4 5 6 7 8 9 10 ...